The chemical process technology used in the production of maxresorb® ensures high reproducibility and safety of the material. Because of its  100 % synthetic character any risk of infection can be excluded.

maxresorb® exhibits a controlled biphasic resorption; initial integration of the particles followed by complete resorption. While the fast resorption of β-TCP quickly offers space for new bone formation, the HA component provides volume stability for an extended time period.

maxresorb® is not only a mixture of HA and β-TCP particles. During the production process HA and β-TCP are brought together in a ceramic slurry, which is then foamed and freeze-dried to form particles containing both phases. The fast resorption of the β-TCP component continuously increases the porosity of the material promoting tissue integration by allowing ingrowth of cells and blood vessels.

The prominent surface roughness of maxresorb® facilitates adhesion of cells and proteins and offers excellent hydrophilicity. maxresorb® is therefore a prominent scaffold for the migration of bone forming cells and binding of signaling molecules from the blood, which lead to accelerated integration and tissue regeneration.

maxresorb®

• mixes well with autogenous bone, blood or saline solution
• retains liquids facilitating quick and extensive wetting of particles with blood or saline solution
• Stickiness of wetted particles allows for quick and easy application to the defect site